ENDRA Life Sciences (NDRA)
(Real Time Quote from BATS)
$4.90 USD
+0.06 (1.24%)
Updated Aug 4, 2025 02:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NDRA 4.90 +0.06(1.24%)
Will NDRA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NDRA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NDRA
What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock
NDRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NDRA
NDRA Sees Lucid Capital Markets as Sole Manager for Recent Offering | NDRA Stock News
Endra Life Sciences files to sell 15.7M shares of common stock
Gold Falls 1%; ProKidney Shares Spike Higher
12 Health Care Stocks Moving In Tuesday's Intraday Session
US Stocks Mixed; Small Business Sentiment Falls In June